Publications by Professor Margaret Bassendine - ePrints

Browsing publications by Professor Margaret Bassendine.

Newcastle Authors	Title	Year
Dr David Sheridan Professor Margaret Bassendine	Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease	2015
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Fiona Fenwick Dr Clare Lanyon et al.	PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism	2015
Professor Margaret Bassendine Dr David Sheridan Jaime Jonsson	CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection	2013
Dr David Sheridan Dr R Neely Professor Margaret Bassendine	Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)	2013
Professor Margaret Bassendine Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Dr R Neely et al.	Lipids and HCV	2013
Professor Margaret Bassendine Professor Stuart McPherson	Liver Stiffness Measurement Assessed by Fibroscan Predicts Response to Anti-Viral Treatment in Patients with Genotype 2 and 3 Chronic Hepatitis C	2013
Dr Matthias Schmid Professor Margaret Bassendine Professor Stuart McPherson	Liver Stiffness Measurement Predicts Response to Anti-Viral Treatment in Patients with Chronic Hepatitis C Genotype 3	2013
Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Fiona Fenwick Emeritus Professor Geoffrey Toms et al.	Metabolic Syndrome and Insulin Resistance are Associated with Maximum Hepatitis C Lipoviral Particles in Genotype 1 Infection	2013
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Fiona Fenwick Professor Margaret Bassendine et al.	Omega-3 Fatty Acids and/or Fluvastatin in Hepatitis C Prior Non-Responders to Combination Anti-Viral Therapy - A Pilot Randomised Clinical Trial	2013
Professor Stuart McPherson Dr Samuel Moses Professor Margaret Bassendine	Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England	2013
Professor Stuart McPherson Dr Samuel Moses Dr Shafiq Rehman Claire Miller Dr Mark Hudson et al.	A pilot of targeted case finding for hepatitis B virus (HBV) and hepatitis C (HCV) in the British South Asian community	2012
Dr David Sheridan Dr Simon Bridge Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity	2012
Dr Enid Michael Dr Andrew Turley Dr Samuel Moses Dr Mark Hudson Professor Margaret Bassendine et al.	Pregnant mothers with chronic hepatitis B (HBV): how often is treatment needed?	2012
Professor Margaret Bassendine Dr David Sheridan	IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study	2011
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic Hepatitis C infection: Evidence for genotype-specific modulation of lipid pathways	2011
Professor Margaret Bassendine Dr David Sheridan Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	HCV and the hepatic lipid pathway as a potential treatment target	2011
Professor Stuart McPherson Dr Mark Hudson Professor Margaret Bassendine	Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England	2011
Professor Stuart McPherson Dr Mark Hudson Professor Margaret Bassendine	Undiagnosed chronic hepatitis B is prevalent in the British-Chinese community of the North East (NE) of England	2011
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Use of intralipid infusion to analyse apolipoprotein B (APOB) and HCV RNA kinetics in chronic infection	2011
Dr R Neely Professor Margaret Bassendine	Antisense technology to lower LDL cholesterol	2010
Dr David Sheridan Professor Kim Bartlett Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	Hypocholesterolaemia in chronic hepatitis C genotype 3 infection is due to both reduced cholesterol production and increased LDL clearance	2010
Dr David Sheridan Professor Kim Bartlett Dr Daniel Felmlee Dr Simon Bridge Emeritus Professor Geoffrey Toms et al.	Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Dr R Neely et al.	Insulin resistance correlates with low density hepatitis C virus particles in genotype 1 infection	2010
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Dr R Neely et al.	Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection	2010
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	Measurement of low-density Apolipoprotein B associated lipoviral particles in hepatitis C virus genotype 1 infection is more clinically relevant than total viral load	2010
Dr Mark Hudson Professor Stuart McPherson Professor Alastair Burt Professor Margaret Bassendine	Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus	2010
Dr Mark Hudson Professor Stuart McPherson Professor Alastair Burt Professor Margaret Bassendine	Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus	2010
Dr Daniel Felmlee Dr David Sheridan Dr Simon Bridge Emeritus Professor Geoffrey Toms Professor Margaret Bassendine et al.	The HCV life-cycle in the vascular compartment	2010
Dr Monique Welten Professor Margaret Bassendine Dr David Sheridan Dr James George	IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy	2009
Dr Simon Bridge Dr David Sheridan Dr Daniel Felmlee Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Apolipoprotein B Associated Hepatitis C Virus (HCV): A Minority of Total Viral Load in Patients with Chronic HCV	2009
Dr David Sheridan Dr David Price Dr Matthias Schmid Emeritus Professor Geoffrey Toms Dr Peter Donaldson et al.	Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin	2009
Dr Lucy Walker Emerita Professor Julia Newton Professor David Jones Professor Margaret Bassendine	Comment on Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis in Primary Biliary Cirrhosis	2009
Dr Daniel Felmlee Dr Simon Bridge Dr David Sheridan Dr Soren Nielsen Emeritus Professor Geoffrey Toms et al.	Large and Buoyant Hepatitis C Virus (HCV) Particles Surge after Patients Consume a High-Fat Meal	2009
Sarah Welsh Dr Soren Nielsen Emeritus Professor Alan Ward Professor Margaret Bassendine	Analysis of reactivity of PBC sera with bacterial antigens modified by xenobiotic exposure	2008
Dr Soren Nielsen Siti Ibrahim Professor Margaret Bassendine Emeritus Professor Geoffrey Toms	Binding of liver derived, low density hepatitis C virus to human hepatoma cells	2008
Dr Soren Nielsen Professor Margaret Bassendine Caroline Martin Daniel Lowther Dr Paul Purcell et al.	Characterization of hepatitis C RNA-containing particles from human liver by density and size	2008
Dr Soren Nielsen Professor Margaret Bassendine	Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies	2008
Dr Martin Prince Professor Margaret Bassendine Dr Mark Hudson Emeritus Professor Oliver James Professor David Jones et al.	A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis	2007
Dr Soren Nielsen Professor Margaret Bassendine Emeritus Professor Geoffrey Toms	Characterization of hepatitis C RNA containing particles from human liver by density and morphology	2007
Dr Soren Nielsen Professor Margaret Bassendine Emeritus Professor Geoffrey Toms	Characterization of hepatitis C virus associated with very low density lipoprotein (VLDL) in infected human serum and liver	2007
Dr Peter Donaldson Professor David Jones Dr John Taylor Emerita Professor Julia Newton Professor Margaret Bassendine et al.	Cytotoxic T-Lymphocyte-Associated Antigen-4 Single Nucleotide Polymorphisms and Haplotypes in Primary Biliary Cirrhosis	2007
Professor Margaret Bassendine	Lipids and infection	2007
Professor Alastair Burt Dr Mark Hudson Professor Margaret Bassendine	The effect of calcineurin inhibitor usage on hepatic fibrosis progression in HCV-positive liver transplant recipients: A two-centre study.	2007
Dr David Price Professor Margaret Bassendine Emeritus Professor Geoffrey Toms Dr Matthias Schmid Dr Christopher Morris et al.	Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection	2006
Dr Soren Nielsen Professor Margaret Bassendine Professor Alastair Burt Caroline Martin Dr Wanna Pumeechockchai et al.	Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients	2006
Dr David Price Dr Matthias Schmid Dr Kaushik Agarwal Wendy Craig Professor Alastair Burt et al.	Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area	2006
Professor Margaret Bassendine	Cost effectiveness of interferon α or peginterferon α with ribavirin for histologically mild chronic hepatitis C	2006
Dr Soren Nielsen Professor Margaret Bassendine Caroline Martin Emeritus Professor Geoffrey Toms	Development of a purification procedure for native hepatitis C virus from human liver	2006
Dr Peter Donaldson Dr Anna Baragiotta Professor David Jones Emeritus Professor Oliver James Professor Margaret Bassendine et al.	HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: A large-scale study	2006
Fiona Fenwick Professor Margaret Bassendine Dr Kaushik Agarwal Professor Debra Bevitt Dr Wanna Pumeechockchai et al.	Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation	2006
Dr David Price Dr Peter Donaldson Julian Leathart Professor Alastair Burt Dr Matthias Schmid et al.	Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis	2006
Dr David Price Professor Alastair Burt Dr Matthias Schmid Wendy Craig Professor Margaret Bassendine et al.	Steatosis in chronic HCV infection: viral and host characteristics	2006
Dr Martin Prince Professor Margaret Bassendine Professor David Jones	Fatigue in primary biliary cirrhosis [1]	2005
Caroline Martin Dr Soren Nielsen Professor Margaret Bassendine Emeritus Professor Geoffrey Toms	Hepatitis C virus lipo-viro-particle interactions with human hepatocytes and inhibition of of binding	2005
Dr Soren Nielsen Professor Alastair Burt Caroline Martin Professor Margaret Bassendine Emeritus Professor Geoffrey Toms et al.	Hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral particles	2005
Dr Soren Nielsen Professor Alastair Burt Caroline Martin Professor Margaret Bassendine Emeritus Professor Geoffrey Toms et al.	Human hepatitis C virus RNA circulates predominantly in VLDL-like lipo-viral-particles	2005
Professor Margaret Bassendine	Infectious aetiology of primary biliary cirrhosis	2005
Professor Matthew Wright Professor Margaret Bassendine	Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: A multicentre randomized controlled trial	2005
Dr David Price Professor Margaret Bassendine Professor Alastair Burt Dr Peter Donaldson	Apolipoprotein E2 protects against persistent hepatitis C virus infection	2004
Dr Soren Nielsen Professor Margaret Bassendine Professor Alastair Burt Professor Debra Bevitt Emeritus Professor Geoffrey Toms et al.	Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver	2004
Dr Anna Baragiotta Dr Kaushik Agarwal Dr Alison Sutherland Professor David Jones Dr Peter Donaldson et al.	Chemokine receptor 5 and primary biliary cirrhosis: A two-centre genetic association study	2004
Professor Margaret Bassendine Professor David Jones	Fatigue and primary biliary cirrhosis: Association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels	2004
Dr David Price Professor Alastair Burt Professor Margaret Bassendine	Host and viral characteristics associated with steatosis in chronic hepatitis C	2004
Dr Anna Baragiotta Dr Kaushik Agarwal Professor David Jones Dr Peter Donaldson Professor Margaret Bassendine et al.	No evidence for involvement of the CCR5 (chemokine receptor-5) delta 32 mutation in primary biliary cirrhosis	2004
Professor David Jones Professor Margaret Bassendine	Primary biliary cirrhosis: Report of a focus study group	2004
Emeritus Professor Oliver James Siddesh Jain Professor Margaret Bassendine	Tamoxifen: A novel treatment for primary biliary cirrhosis?	2004
Professor Margaret Bassendine	The Molecular Basis of Primary Biliary Cirrhosis	2004
Dr Martin Prince Professor Margaret Bassendine	A retrospective study of weight loss during alpha-interferon (alpha-IFN) therapy for chronic hepatitis C (HCV)	2003
Professor Alastair Burt Caroline Martin Professor Margaret Bassendine Emeritus Professor Geoffrey Toms	Association of HCV particles with LDL/VLDL: Analysis using isotonic iodixanol gradient centrifugation & real time PCR	2003
Dr John Taylor Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones Dr Peter Donaldson et al.	Caspase 8 gene polymorphism is associated with primary biliary cirrhosis	2003
Dr Soren Nielsen Professor Margaret Bassendine Professor Alastair Burt Emeritus Professor Geoffrey Toms	Characterisation of the genome and structural proteins of beta-lipoprotein associated HCV extracted from infected human liver	2003
Professor Margaret Bassendine	Primary Biliary Cirrhosis	2003
Professor Margaret Bassendine	The Effective Management of Hepatitis C Infection	2003
Dr David Price Dr Kaushik Agarwal Dr Matthias Schmid Professor Alastair Burt Professor Margaret Bassendine et al.	The hepatitis C virus (HCV) epidemic; spectrum of chronic liver disease in a single UK centre	2003
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor Margaret Bassendine Professor David Jones et al.	[abstract] Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC)	2002
Dr Martin Prince Wendy Craig Dr Matthias Schmid Professor Margaret Bassendine	A retrospective study of weight loss during alpha-inter feron (alpha-IFN) therapy for chronic hepatitis C (HCV)	2002
Dr Anna Baragiotta Emeritus Professor Oliver James Wendy Craig Dr Denis Burke Dr Malcolm Bateson et al.	Autoimmune hepatitis (AIH): Clinical spectrum of disease defined by revised international autoimmune hepatitis group (IAHG) scoring system	2002
Dr John Taylor Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones Dr Peter Donaldson et al.	Caspase 8 gene polymorphism is associated with primary biliary cirrhosis	2002
Dr Soren Nielsen Dr Wanna Pumeechockchai Professor Alastair Burt Professor Margaret Bassendine Emeritus Professor Geoffrey Toms et al.	Characterization of HCV RNA particles from the serum of a patient with common variable immunodeficiency on isotonic iodixanol (optiprep) gradients. Association with apolipoprotein-B100	2002
Dr Soren Nielsen Professor Margaret Bassendine Alison Burt Emeritus Professor Geoffrey Toms	Characterization of the structural proteins of HCV isolated from human liver	2002
Dr Kaushik Agarwal Professor Margaret Bassendine	Hepatitis associated with Chinese herbs	2002
Dr Wanna Pumeechockchai Professor Debra Bevitt Dr Kaushik Agarwal Professor Margaret Bassendine Emeritus Professor Geoffrey Toms et al.	Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody	2002
Professor Margaret Bassendine	How to respond to abnormal liver function tests	2002
Emerita Professor Julia Newton Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones	Osteoporosis is not a specific complication of primary biliary cirrhosis	2002
Dr Martin Prince Professor Margaret Bassendine Professor David Jones	Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis (PBC)	2002
Professor Margaret Bassendine Professor David Jones	Reduced pallidal magnetisation transfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis [abstract]	2002
Dr Birju Rana Dr Chris Redfern Professor Derek Manas Professor Margaret Bassendine	Retinoic acid receptor-selective ligands and hepatocellular carcinoma (HCC)	2002
Dr Matthias Schmid Professor Alastair Burt Professor Margaret Bassendine	The hepatitis C virus (HCV) epidemic; Spectrum of chronic liver disease in a single UK centre	2002
Dr Martin Prince Dr Anna Baragiotta Professor Margaret Bassendine Emeritus Professor Oliver James Professor David Jones et al.	The true impact of fatigue in primary biliary cirrhosis: A population study	2002
Dr Anna Baragiotta Professor David Jones Dr Kaushik Agarwal Emeritus Professor Oliver James Professor Margaret Bassendine et al.	Genetic susceptibility to primary biliary cirrhosis (PBC): Analysis of chemokine receptor 5 (CCR5) delta32 deletion	2001
Professor Margaret Bassendine Dr Raymond Barry	Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study	2001
Wendy Craig Emeritus Professor Oliver James Dr Denis Burke Professor Melissa Bateson Professor Margaret Bassendine et al.	Is the revised international autoimmune hepatitis group (IAHG) scoring system useful?	2001
Dr Sarah Jowett Dr Kaushik Agarwal Dr Eilish Gilvarry Professor Alastair Burt Professor Margaret Bassendine et al.	Managing chronic hepatitis C acquired through intravenous drug use	2001
Dr Sarah Jowett Dr Kaushik Agarwal Dr Eilish Gilvarry Professor Alastair Burt Professor Margaret Bassendine et al.	Managing chronic hepatitis C acquired through intravenous drug use	2001
Emerita Professor Julia Newton Emeritus Professor Roger Francis Emeritus Professor Oliver James Professor Margaret Bassendine Professor David Jones et al.	Osteoporosis in primary biliary cirrhosis revisited	2001
Dr Alberto Lopes Professor Margaret Bassendine	Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation	2001
Dr Anna Baragiotta Emeritus Professor Oliver James Professor Melissa Bateson Professor Margaret Bassendine	Validation of the revised International Autoimmune Hepatitis Group (IAHG) scoring system: Experience in the north of England	2001
Dr Anna Baragiotta Emeritus Professor Oliver James Professor David Jones Joanne Newton Professor Margaret Bassendine et al.	Vitamin D receptor (VDR) TaqI polymorphism in primary biliary cirrhosis (PBC)	2001
Professor David Jones Professor Ann Daly Emeritus Professor Oliver James Dr Bijayeswar Vaidya Professor Simon Pearce et al.	CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis	2000
Professor Ann Daly Professor Margaret Bassendine Professor Chris Day	Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease	2000
Dr Jeremy Palmer Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones et al.	Secretory autoantibodies in primary biliary cirrhosis (PBC)	2000
Dr Mark Welfare Professor Margaret Bassendine Professor Ann Daly	The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects	2000
Dr Margaret Jackson Professor Debra Bevitt Emeritus Professor Geoffrey Toms Professor Margaret Bassendine	Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals	1999
Dr Kaushik Agarwal Professor David Jones Professor Ann Daly Professor Margaret Bassendine	CTLA-4 gene polymorphism and chronicity in viral hepatitis	1999
Dr Kaushik Agarwal Professor David Jones Professor Ann Daly Professor Margaret Bassendine Dr Mark Hudson et al.	CTLA-4 gene polymorphism and susceptibility to inflammatory bowel disease (IBD)	1999
Dr Mark Welfare Emeritus Professor Murray Aitkin Professor Margaret Bassendine Professor Ann Daly	Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: Lack of a polymorphism in CYP1A2 in Caucasians	1999
Marian Case Professor Alastair Burt Joan Hughes Dr Jeremy Palmer Professor Margaret Bassendine et al.	Erratum to 'Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol' (Journal of Immunological Methods (1999) 223 (93-106))	1999
Professor David Jones Professor Margaret Bassendine Emeritus Professor Oliver James	Familial primary hiliary cirrhosis reassessed: A geographically-based population study	1999
Dr Kaushik Agarwal Professor David Jones Professor Margaret Bassendine	Genetic susceptibility to primary biliary cirrhosis [Review]	1999
Dr Peter Donaldson Dr Kaushik Agarwal Emeritus Professor Oliver James Professor Margaret Bassendine	Interleukin-1 beta gene polymorphisms are associated with disease progression in primary biliary cirrhosis	1999
Dr Sarah Jowett Dr Kaushik Agarwal Professor Margaret Bassendine	Medical management of chronic hepatitis C in intravenous drug users	1999
Professor Margaret Bassendine Professor Ann Daly	Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer	1999
Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones	T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)	1999
Professor David Jones Emerita Professor Julia Newton Professor Ann Daly Professor Chris Day Emeritus Professor Oliver James et al.	Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis	1999
Professor David Jones Emeritus Professor Oliver James Professor Margaret Bassendine	Primary biliary cirrhosis: clinical and associated autoimmune features and natural history	1998
Professor Ann Daly Professor Margaret Bassendine Emeritus Professor Oliver James Professor Chris Day	The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: Effect on age of presentation and dependence on alcohol dehydrogenase genotype	1998
Professor Debra Bevitt Dr Gavin Spickett Emeritus Professor Geoffrey Toms Professor Margaret Bassendine	Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: A comparison of immunodeficient and immunocompetent patients	1996
Professor Helen Reeves Professor Derek Manas Professor Margaret Bassendine Dr Mark Hudson Emeritus Professor Oliver James et al.	Intravenous bisphosphonate pre liver transplant prevents osteoporotic vertebral collapse	1996
Dr Kun Guo Dr Felicity May Dr Mark Bennett Dr Ian Corbett Professor Margaret Bassendine et al.	C-erbb-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma	1992
Dr Christine Challen Professor John Lunec Professor Margaret Bassendine	Analysis of the p53 tumour suppressor gene in HCCs from Britain.	1992
Dr Christine Challen Professor Margaret Bassendine	Infrequent point mutations in codons 12 and 61 of Ras oncogenes in HCC.	1992
Professor John Lunec Professor Margaret Bassendine	P53 - A frequent target for genetic abnormalities in human hetatocellular carcinomas (HCCS) in Britain	1991
Professor Margaret Bassendine Professor Nicola Curtin Dr Henry Loose Emeritus Professor Oliver James	Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. A phase II study.	1987
Professor Margaret Bassendine Professor Nicola Curtin Emeritus Professor Oliver James	A new thymidylate synthase (TS) inhibitor, CB3717, in human primary liver cancer (PLC) - invitro, xenograft and phase-II studies	1986
Professor Margaret Bassendine Professor Nicola Curtin Emeritus Professor Oliver James	Induction of remission in primary liver cell cancer PLC with a new thymidylate synthase inhibitor, CB3717: a phase II study	1986
Professor Nicola Curtin Emeritus Professor Oliver James Professor Margaret Bassendine	Inhibition of the growth of human hepatocellular-carcinoma invitro and in athymic mice by a quinazoline inhibitor of thymidylate suntjase, CB3717	1986
Emeritus Professor Oliver James Professor Nicola Curtin Professor Margaret Bassendine	Primary hepatocellular carcinoma localised by a radiolabelled monoclonal antibody	1986
Emeritus Professor Oliver James Professor Margaret Bassendine Professor Nicola Curtin	Localization of primary hepatocellular carcinoma by a radiolabeled monoclonal antibody	1985
Emeritus Professor Oliver James Professor Margaret Bassendine Professor Nicola Curtin	Primary hepatocellular carcinoma localization using a radiolabeled monoclonal antibody	1985
Professor Margaret Bassendine Emeritus Professor Oliver James Professor Nicola Curtin	Localization of primary hepatocellular carcinoma using a radiolabeled monoclonal antibody	1984
Professor Margaret Bassendine Professor Nicola Curtin Emeritus Professor Oliver James	Successful treatment of human primary liver cancer xenograft by new quinazoline anti folate agent CB 3717	1983